# Altium Capital

Altium Capital is a Single Family Office based in New York, United States.

## Overview

- **Organization type:** Single Family Office
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** 152 W 57th Street FL 20, New York, NY 10019, United States
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** altiumcap.com
- **LinkedIn:** https://www.linkedin.com/company/altium-capital

## Regulatory record

- **Reports private funds:** No

## About

Altium Capital was established in 2017 by Jacob Gottlieb in New York. Gottlieb previously built Visium Asset Management from a spinout of Balyasny Asset Management into an $8 billion platform before launching the current firm. The office manages private wealth through alternative investments with a primary emphasis on healthcare. The firm deploys capital into therapeutics via direct co-investments, SPVs, hedge fund strategies, and private equity structures. It covers early-stage, seed, pre-seed, and growth opportunities. Confirmed holdings include Antios Therapeutics, Cerevel Therapeutics, Chemomab Therapeutics, eGenesis, Gemini Therapeutics, Hummingbird Bioscience, Hyperfine, Immunovant, Ocuphire Pharma, Palisade Bio, Quoin Pharmaceuticals, Sagimet Biosciences, Seelos Therapeutics, Sonnet BioTherapeutics, Timber Pharmaceuticals, Vincerx Pharma, and Yumanity Therapeutics. Co-investors have included Abingworth, Bain Capital Life Sciences, OrbiMed, Novo Holdings, Frazier Healthcare Partners, and Sio Capital Management. Activity centers on North America with additional exposure through cross-border financings. Team size remains undisclosed. The firm lists one headquarters office in New York. Philanthropic vehicles include Altium Cares along with grants to the East Harlem Tutorial Program, New Yorkers for Children, Niskanen Center, Robin Hood Foundation, and The Windward School. No dated operational events from the last 24 months appear in available records. Altium Capital maintains a hybrid posture that combines single-family office capital with external co-investment syndicates. This structure allows the firm to lead or participate in PIPEs and venture rounds while sharing risk with other healthcare specialists such as Ikarian Capital and 683 Capital.

## Sectors

- Healthcare Services
- Digital Health
- Biotech

## People

- Jacob Gottlieb — Managing Partner and Chief Investment Officer
- Mark Gottlieb — Chief Operating Officer
- Joshua Thomas — Investment professional
- Andrew Loggia — Chief Financial Officer
- Deborah Wolfe — Management Company Accountant

## Questions

### Who runs investment decisions at Altium Capital?

Jacob Gottlieb serves as Managing Partner and Chief Investment Officer. He previously founded and led Visium Asset Management to approximately $8 billion AUM.

### How does Altium Capital source proprietary deal flow?

The firm relies on sector expertise in therapeutics and networks developed through prior Visium investments and co-investor relationships.

### Is Altium Capital structured as a single family office or does it operate more like a venture firm?

Research records classify it as a single-family office. Public materials describe it as an alternative investment manager focused on healthcare.

### Does Altium Capital participate in fund commitments or only direct deals?

The firm executes direct co-investments and SPVs alongside hedge fund and private equity strategies.

### What investment stages does Altium Capital typically target?

It covers early stage, growth, pre-seed, and seed opportunities, with emphasis on pre-clinical development phases.

### What is Altium Capital's known posture on co-investments alongside external GPs?

It regularly co-invests with institutions including Abingworth, OrbiMed, Novo Holdings, and Sio Capital Management in PIPEs and venture rounds.

## Related profiles

- [Altiqa Group](https://altss.com/profile/altiqa-group)
- [Altium Wealth Architecture](https://altss.com/profile/altium-wealth-architecture)

---

Last updated: 2026-08-10T15:54:10.904Z

Canonical page: https://altss.com/profile/altium-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology